| Circulating TNF‐α, TGF‐β, and IL‐10 in Tuberculosis Patients and Healthy Contacts JO Olobo, M Geletu, A Demissie, T Eguale, K Hiwot, G Aderaye, S Britton Scandinavian journal of immunology 53 (1), 85-91, 2001 | 171 | 2001 |
| Housekeeping genes; expression levels may change with density of cultured cells S Greer, R Honeywell, M Geletu, R Arulanandam, L Raptis Journal of immunological methods 355 (1-2), 76-79, 2010 | 147 | 2010 |
| T-Cell Recognition of Mycobacterium tuberculosisCulture Filtrate Fractions in Tuberculosis Patients and Their Household Contacts A Demissie, P Ravn, J Olobo, TM Doherty, T Eguale, M Geletu, W Hailu, ... Infection and immunity 67 (11), 5967-5971, 1999 | 93 | 1999 |
| The R (h) oads to Stat3: Stat3 activation by the Rho GTPases L Raptis, R Arulanandam, M Geletu, J Turkson Experimental cell research 317 (13), 1787-1795, 2011 | 92 | 2011 |
| Target proteins of C/EBPαp30 in AML: C/EBPαp30 enhances sumoylation of C/EBPαp42 via up-regulation of Ubc9 M Geletu, MY Balkhi, AA Peer Zada, M Christopeit, JA Pulikkan, ... Blood, The Journal of the American Society of Hematology 110 (9), 3301-3309, 2007 | 89 | 2007 |
| Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML JA Pulikkan, V Dengler, AA Peer Zada, A Kawasaki, M Geletu, Z Pasalic, ... Leukemia 24 (5), 914-923, 2010 | 74 | 2010 |
| Nanomolar-potency small molecule inhibitor of STAT5 protein AA Cumaraswamy, AM Lewis, M Geletu, A Todic, DB Diaz, XR Cheng, ... ACS medicinal chemistry letters 5 (11), 1202-1206, 2014 | 72 | 2014 |
| Proteomics of acute myeloid leukaemia: cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications MY Balkhi, AK Trivedi, M Geletu, M Christopeit, SK Bohlander, HM Behre, ... Oncogene 25 (53), 7041-7058, 2006 | 66 | 2006 |
| STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation M Singh, N Garg, C Venugopal, R Hallett, T Tokar, N McFarlane, ... Oncotarget 6 (29), 27461, 2015 | 61 | 2015 |
| Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration R Arulanandam, M Geletu, H Feracci, L Raptis Experimental cell research 316 (5), 875-886, 2010 | 52 | 2010 |
| Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt M Niit, V Hoskin, E Carefoot, M Geletu, R Arulanandam, B Elliott, L Raptis Biomolecular concepts 6 (5-6), 383-399, 2015 | 44 | 2015 |
| Beyond structure, to survival: activation of Stat3 by cadherin engagement L Raptis, R Arulanandam, A Vultur, M Geletu, S Chevalier, H Feracci Biochemistry and Cell Biology 87 (6), 835-843, 2009 | 44 | 2009 |
| Proteomic discovery of Max as a novel interacting partner of C/EBPα: a Myc/Max/Mad link AA Zada, JA Pulikkan, D Bararia, M Geletu, AK Trivedi, MY Balkhi, ... Leukemia 20 (12), 2137-2146, 2006 | 41 | 2006 |
| Identification and characterization of AES-135, a hydroxamic acid-based HDAC inhibitor that prolongs survival in an orthotopic mouse model of pancreatic cancer AE Shouksmith, F Shah, ML Grimard, JM Gawel, YS Raouf, M Geletu, ... Journal of medicinal chemistry 62 (5), 2651-2665, 2019 | 35 | 2019 |
| Classical cadherins control survival through the gp130/Stat3 axis M Geletu, R Arulanandam, S Chevalier, B Saez, L Larue, H Feracci, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (8), 1947-1959, 2013 | 35 | 2013 |
| Engaged for survival: From cadherin ligation to STAT3 activation M Geletu, S Guy, R Arulanandam, H Feracci, L Raptis Jak-Stat 2 (4), e27363, 2013 | 31 | 2013 |
| AML1/ETO–induced survivin expression inhibits transcriptional regulation of myeloid differentiation MY Balkhi, M Christopeit, Y Chen, M Geletu, G Behre Experimental hematology 36 (11), 1449-1460. e1, 2008 | 30 | 2008 |
| Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ... Journal of medicinal chemistry 64 (12), 8486-8509, 2021 | 29 | 2021 |
| A selective inhibitor of the UFM1-activating enzyme, UBA5 SR da Silva, SL Paiva, M Bancerz, M Geletu, AM Lewis, J Chen, Y Cai, ... Bioorganic & medicinal chemistry letters 26 (18), 4542-4547, 2016 | 26 | 2016 |
| Mind the gap; regulation of gap junctional, intercellular communication by the SRC oncogene product and its effectors M Geletu, A Trotman-Grant, L Raptis Anticancer research 32 (10), 4245-4250, 2012 | 25 | 2012 |
